Articles tagged "Elderly patients"

2020 American Transplant Congress
Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist and Deceased-Donor Kidney Transplant Outcomes among Older Recipients
J. Ahn¹, S. Bae¹, K. Lentine², M. Schnitzler², G. Hess³, D. Segev¹, M. McAdams-DeMarco¹
¹Johns Hopkins University, Baltimore, MD, ²Saint Louis University, St. Louis, MO, ³Drexel University, Philadelphia, PA
*Purpose: Kidney transplantation (KT) has been growing treatment option for older end-stage renal disease patients. Although lymphocyte-depleting agents are considered to be superior than interleukin-2…
2020 American Transplant Congress
Ehrlichiosis Infection Presenting as Thrombotic Microangiopathy Early after Kidney Transplantation
W. Hassan¹, M. Talwar², V. Balaraman², B. Wall¹, M. Molnar¹
¹Medicine-Nephrology, University of Tennessee Health Science Center, Memphis, TN, ²Department of Surgery, Transplant Surgery, Methodist University Hospital, James D Eason Transplant Institute, Memphis, TN
*Purpose: Fever of unknown origin and clinical picture of Thrombotic MicroAngiopathy (TMA) are diagnostic challenges in the early period after kidney transplantation. Here we present…
2020 American Transplant Congress
Impact of Functional Status on Outcomes of Simultaneous Pancreas-Kidney Transplantation: Risks and Opportunities for Patient Benefit
K. Lentine¹, T. Alhamad², M. Cooper³, Z. Zhang⁴, K. Woodside⁵, D. Dadhania⁶, S. Chang², D. Axelrod⁷, M. Schnitzler⁴, R. Ouseph¹, J. Snyder⁸, B. Kasiske⁸, R. Parsons⁹
¹Department of Medicine, Saint Louis University, Saint Louis, MO, ²Washington Univ, Seattle, WA, ³Georgetown Univ, Washington, DC, ⁴Saint Louis University, Saint Louis, MO, ⁵Univ of Michigan, Ann Arbor, MI, ⁶Weill Cornell, New York, NY, ⁷Univ of Iowa, Iowa City, IA, ⁸SRTR, Minneapolis, MN, ⁹Emory, Atlanta, GA
*Purpose: The impact of functional status on survival among simultaneous pancreas-kidney transplant (SPKT) candidates and recipients is not well described.*Methods: We examined national Scientific Registry…
2020 American Transplant Congress
80 is the New 60: A Single-Center Outcome Study of Octogenarian Kidney Transplant Recipients
D. Shankaranarayanan, T. Muthukumar, S. Sultan, A. Watkins, D. Serur, C. Hartono
Weill Cornell Medicne, New York City, NY
*Purpose: Kidney transplantation is the treatment of choice for end stage renal disease. However, limited data is available on the outcomes of octogenarian recipients.*Methods: Retrospective…
2020 American Transplant Congress
Improving Eligibility of Renal Transplants in the Elderly
L. B. Moraitis¹, J. Rogers², A. Farney¹, A. Reeves-Daniel¹, G. Orlando¹, W. Doares¹, S. Kaczmorski¹, A. Mena-Gutierrez¹, C. Jay¹, R. Stratta¹
¹Abdominal Organ Transplant, Wake Forest Baptist Health, Winston-Salem, NC, ²Surgery, Wake Forest Baptist Health, Winston-Salem, NC
*Purpose: In the recent past, older age was a contraindication to kidney transplantation (KT). New kidney allocation schemes with use of longevity matching, initiation of…
2020 American Transplant Congress
Managing the Road to Kidney Transplantation in the Elderly
R. S. Munjal, K. Kalra, A. Cherukuri, D. Jorgensen, S. Verma, P. Sood, R. Mehta, C. Puttarajappa, S. Hariharan, C. Wu
Nephrology, UPMC, Pittsburgh, PA
*Purpose: We hypothesize that careful patient selection and waitlist management minimizes the impact of advanced recipient age on kidney transplant outcomes.*Methods: A total of 3,521…
2020 American Transplant Congress
Low-Dose Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients at High Immunologic Risk is Safe and May Prevent Excess Rejection
E. Sartain¹, B. Nettles¹, B. Crowther¹, P. Klem¹, K. Schwarz¹, S. Davis²
¹University of Colorado Hospital, Aurora, CO, ²University of Colorado School of Medicine, Aurora, CO
*Purpose: Patients aged ≥65 years are a growing segment of kidney transplant recipients (KTRs). Consensus on induction immunosuppression in this population is unclear given higher…
2020 American Transplant Congress
Outcome of over 65 Years Old ESRD Patients Referred for Pre-Kidney Transplant Evaluation
A. M. Alabadi¹, A. H. Shaqaq¹, K. F. Hamawi¹, A. A. Alqatari², M. Alaskar², B. S. Alsadah², A. A. Alomran², K. B. Akkari¹
¹Multi Organ Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia, ²Faculty of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia
*Purpose: Potential kidney transplant recipients over the age of 65 years of age form a significant proportion of the total referred for kidney transplant evaluation.…
2019 American Transplant Congress
Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients
C. Pham, S. Kuten, A. Rogers, R. Knight, D. T. Nguyen, E. Graviss, A. Gaber
Houston Methodist Hospital, Houston, TX
*Purpose: It is well recognized that elderly transplant recipients experience lower rates of acute rejection along with higher rates of infectious death compared to their…
2019 American Transplant Congress
Outcomes after Incompatible Living Donor Kidney Transplantation in Older Recipients
J. Long¹, K. Jackson¹, J. Motter¹, S. Bae¹, A. Massie¹, M. Waldram¹, K. Covarrubias¹, J. Chen¹, B. Orandi², N. Desai¹, D. Segev¹, J. Garonzik-Wang¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²Surgery, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Older individuals are the fastest-growing sub-group of transplant candidates who may face increased risks when considering incompatible living donor kidney transplantation (IKT) due to…

« Previous Page
1
…
4
5
6
7
8
…
17
Next Page »